Hot Stocks

The stock market changes from minute to minute, and what’s hot today may not be hot tomorrow. Our expert analysts spot hot stocks that are heating up before the crowd swoops in to bid prices higher, and our journalists sift through the noise to shine a light on trending investments -- in spaces ranging from quantum computing to marijuana stocks -- to determine whether they’re actually worth your time.

Weak Sales Growth Hurts Verizon (VZ) Rating

By Portfolio Grader
Verizon Communication Inc (NYSE:VZ) is a component of the 46 company Diversified Telecommunication Services GICS industry group, which is part of the 67 company GICS Telecommunication Services sector. The market value of VZ is $195.2 billion which places it in the top decile in its industry group. The current Portfolio Grader ranking for VZ puts it 29 among the 46 companies in this industry group, giving it a lower than average position; in the third quartile of the sector with a ranking of 44 among the 67 companies in the sector, and number 2,720 in the nearly 5,000 company Portfolio Grader universe.

Novartis AG (NVS) a Hold on Anemic Industry Group Rank

By Portfolio Grader
Currently, Novartis AG (NYSE:NVS) has a Hold using the methodology of Louis Navellier for investing and his Portfolio Grader stock evaluator. This represents no change from the previous week and is the same ranking NVS has had from Portfolio Grader for 2 months.

China Mobile (CHL) a Sell on Adverse Sales Growth

By Portfolio Grader
China Mobile Ltd (NYSE:CHL) is one of the 67 companies in the GICS Telecommunication Services sector, and a member of the 21 company Wireless Telecommunication Services GICS industry group within this sector. CHL has a market value of $207.2 billion which is in the top decile in its industry group. The current Portfolio Grader ranking for CHL puts it 16 among the 21 companies in this industry group, a position that is well below-average; squarely in the bottom quartile of the sector with a ranking of 51 among the 67 companies in the sector, and number 3,379 in the nearly 5,000 company Portfolio Grader universe.

Quant Score Analytics Limit Pfizer (PFE) Upgrade to Hold

By Portfolio Grader
Currently, Pfizer Inc (NYSE:PFE) has a Hold using Louis Navellier's investing methodology and his Portfolio Grader stock evaluator. PFE has been upgraded from a Sell to a Hold in the last week.

Stock of AT&T (T) Downgraded to Sell

By Portfolio Grader
Currently, AT&T Inc (NYSE:T) has a Sell using the methods of Louis Navellier for investing and his Portfolio Grader stock evaluator. T has been downgraded from a Hold to a Sell in the last week.

High-End Sales Growth Metrics Raise Ranking of Chevron (CVX) to Strong Buy

By Portfolio Grader
Currently, Chevron Corp (NYSE:CVX) has a Strong Buy using the stock evaluator from Portfolio Grader, which incorporates Louis Navellier's investing approach. CVX has been upgraded from a Buy to a Strong Buy in the last week.

Quant Score Keeps Exxon Mobil (XOM) a Sell

By Portfolio Grader
The current recommendation of Sell for Exxon Mobil Corp (NYSE:XOM) is computed using Louis Navellier's Portfolio Grader stock evaluator, which incorporates his investing methodology. XOM has maintained this ranking for 7 months.

Johnson & Johnson’s (JNJ) Strong Quant Score Makes it a Buy

By Portfolio Grader
Johnson & Johnson Co (NYSE:JNJ) is ranked as a Buy using Louis Navellier's Portfolio Grader stock evaluator, which incorporates his investing methodology. This represents no change from the previous week and is the same ranking JNJ has had from Portfolio Grader for 7 months.

NVIDIA Corporation Seems Unstoppable But Watch Out for the Herd Mentality

By Will Healy, InvestorPlace Contributor
Nvidia investors have had a good ride on key technological advances. At this point, NVDA stock could be a risky buy.

Paypal Holdings Inc (PYPL) Q3 Earnings Ahead of the Mark

By Karl Utermohlen, InvestorPlace Writer
Paypal (PYPL) posted its third-quarter earnings and revenue after the bell Thursday, topping expectations. The company updated its outlook.

Why Sally Beauty Holdings, Inc. (SBH) Shares Are Sinking Today

By Karl Utermohlen, InvestorPlace Writer
Sally Beauty (SBH) shares fell more than 5% Thursday due to the possibility that Amazon (AMZN) may attempt to take over the beauty company.

Blue Apron Layoffs: 300+ Employees Get Chopped

By Karl Utermohlen, InvestorPlace Writer
Blue Apron (APRN) announced that the company would be shedding its workforce by 6%, amounting to roughly 300 workers who will be let go.

Black Monday 1987: 12 Things to Remember 30 Years Later

By William White, InvestorPlace Writer
'InvestorPlace' is remembering the stock market crash of 1987, now known as Black Monday, 30 years after the event took place.

Why Adobe Systems Incorporated (ADBE) Stock Is Soaring Today

By Karl Utermohlen, InvestorPlace Writer
Adobe (ADBE) posted its quarterly earnings outlook Thursday and updated its guidance, sending shares up as its outlook impressed investors.

Lousy Quant Score Keeps Evolent Health (EVH) a Sell

By Portfolio Grader
Evolent Health Inc (NYSE:EVH) ranks in the upper half of its industry group, Health Care Technology, and in the top half of its sector group, Health Care, with a market value of $1.1 billion. From an investment attractiveness vantage point, EVH is ranked in the third quartile of the sector with a ranking of 559 among the 783 companies in the sector; the stock's current Portfolio Grader ranking places it 21 among the 26 companies in this industry group, a position that is well below-average and number 3,655 in the 5000 company Portfolio Grader company universe.

Earnings Visibility Hurts HMS Holdings (HMSY) Rating

By Portfolio Grader
Currently, HMS Holdings Corp (NASDAQ:HMSY) has a Hold using Louis Navellier's investing methods and his Portfolio Grader stock evaluator. HMSY has maintained this ranking for the last month.

You Should Buy Rite Aid Corporation Stock Only If This Happens

By James Brumley, InvestorPlace Feature Writer
RAD stock is enticing at a price of less than $2 per share following an 80% pullback. Rite Aid still has one big problem to solve, though.

Solid Quant Score Keeps Omnicell (OMCL) a Buy

By Portfolio Grader
Omnicell Inc (NASDAQ:OMCL) is a constituent of the 26 company Health Care Technology GICS industry group, which is a segment of the 783 company GICS Health Care sector. The market value of OMCL is $1.9 billion which places it in the top half of its industry group. Currently, the stock's Portfolio Grader ranking places it 6 among the 26 companies in this industry group, giving it a well above-average position; in the top quartile of the sector with a ranking of 137 among the 783 companies in the sector, and number 1,034 in the nearly 5,000 company Portfolio Grader universe.

Analysis of Earnings Visibility Keeps Allscripts Healthcare Solutions (MDRX) a Sell

By Portfolio Grader
Allscripts Healthcare Solutions (NASDAQ:MDRX) is classified as a constituent of the 26 company Health Care Technology GICS industry group, which is a segment of the 783 company GICS Health Care sector. MDRX has a market value of $2.5 billion which is in the upper half of its industry group. The stock's current Portfolio Grader ranking places it 20 among the 26 companies in this industry group, a position that is well below-average; in the third quartile of the sector with a ranking of 558 among the 783 companies in the sector, and number 3,653 in the nearly 5,000 company Portfolio Grader universe.
Load More Articles